BRK-B vs NAKA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
NAKA exhibits critical financial distress, anchored by a Piotroski F-Score of 1/9, indicating severe weakness across nearly all fundamental health dimensions. The company has suffered a catastrophic price collapse, falling from a 52-week high of $34.77 to $0.24, reflecting a loss of nearly 99% of its value. Operational efficiency is non-existent with an operating margin of -514.88% and a Quick Ratio of 0.10, signaling a severe liquidity crisis. Despite a 'strong_buy' analyst consensus, the data reveals a company with shrinking revenues (-26.3%) and negative returns on equity.
Compare Another Pair
Related Comparisons
BRK-B vs NAKA: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Nakamoto Inc. (NAKA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.